Welcome to our dedicated page for Pacific Health SEC filings (Ticker: PFHO), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SEC filings page for Pacific Health Care Organization, Inc. (PFHO) provides access to the company’s regulatory disclosures, including annual reports on Form 10-K, quarterly reports on Form 10-Q and current reports on Form 8-K. In these documents, the company reports details such as total revenues, net income and cash flows for recent periods, along with narrative discussion of factors affecting its results, including prior forgiveness of Paycheck Protection Program loans.
For investors analyzing a healthcare plans company focused on workers’ compensation cost containment, the Form 10-K and Form 10-Q filings are key sources of information on how Pacific Health Care Organization, Inc. describes its business model, risk factors and operating environment. The company explains that it specializes in workers’ compensation cost containment through services such as Health Care Organizations, Medical Provider Networks, medical case management, utilization review, medical bill review, workers’ compensation carve-outs and Medicare set-aside services, plus lien representation and expert witness testimony as ancillary services.
Form 8-K filings highlight material events. One such 8-K describes lawsuits filed on September 16, 2025, by wholly owned subsidiaries Medex Healthcare, Inc. and Medex Medical Management, Inc. in the Superior Court of the State of California, County of Orange, against former executives. The complaints allege causes of action including breach of contract, breach of the implied covenant of good faith and fair dealing, breach of fiduciary duty, misappropriation of trade secrets, unfair business act or practice, intentional interference with economic advantage and, in one case, violation of the Comprehensive Computer Data Access and Fraud Act.
On Stock Titan, PFHO filings are updated from the SEC’s EDGAR system, and AI-powered tools can help readers quickly identify the sections of lengthy 10-K, 10-Q and 8-K documents that discuss workers’ compensation services, financial performance and disclosed legal proceedings.
Pacific Health Care Organization, Inc. reports that total revenue for fiscal year 2025 increased 11% from 2024, driven by strong gains in medical case management, which rose 42%, and solid growth in MPN and utilization review revenue. HCO and medical bill review revenue declined modestly, and other services fell sharply.
The company focuses on California workers’ compensation cost containment through licensed Health Care Organizations and 21 approved Medical Provider Networks, plus bill review, utilization review and case management services. As of March 17, 2026, it had 12,800,000 common shares outstanding and non‑affiliate equity market value of about $3,499,200.
Risks include heavy reliance on a small number of customers, outsourcing of key IT and operational functions, regulatory dependence on California licensing and URAC accreditation, cybersecurity exposure highlighted by a 2023 vendor breach, competition from larger managed care and insurance players, and potential disruption from technology shifts such as AI. The company operated with 30 full‑time and one part‑time employees as of March 17, 2026, using a largely remote workforce anchored by a small Irvine, California office.
Pacific Health Care Organization (PFHO) reported Q3 2025 results. Revenue was $1,586,984 and net income was $223,002, or $0.02 per diluted share. Year to date, revenue reached $5,132,339 and net income was $1,152,572, or $0.09 per diluted share, reflecting stronger operations and one-time items.
Q3 growth came from higher medical case management revenue (up 40%) and utilization review (up 9%), offset by declines in HCO (down 25%) and Other revenue. For the first nine months, medical case management rose 53% as employee advocate services expanded. Other income was boosted by Employee Retention Credit refunds received of $488,655, recorded as $419,801 in other income and $68,854 in interest. The company ended the quarter with cash of $2,178,688, U.S. Treasury bill investments of $9,833,845, and stockholders’ equity of $12,839,775. Two customers accounted for 34% of nine‑month sales, highlighting concentration. As of November 4, 2025, shares outstanding were 12,800,000.